Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails (Q44398113)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2003
edit
Language Label Description Also known as
English
Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails
scientific article published in May 2003

    Statements

    Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit